Advanced Leiomyosarcoma clinical trials

Explore recruiting advanced leiomyosarcoma clinical trials.

Recruiting advanced leiomyosarcoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Leiomyosarcoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized & Observational phase II trial comparing the activity of TrabectedIn vs gemCitabine in patients with metastatic or locally advanced LEiomyosarcoma pretreated with conventional chemotherapy

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Advanced Leiomyosarcoma trials by city

Advanced Leiomyosarcoma clinical trials

Recruiting advanced leiomyosarcoma studies right now

Agnostic Therapy in Rare Solid Tumors

Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma

Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma

A Study of Ivonescimab in People With Leiomyosarcoma

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma

A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions

Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Also recruiting in Europe

A Randomized & Observational phase II trial comparing the activity of TrabectedIn vs gemCitabine in patients with metastatic or locally advanced LEiomyosarcoma pretreated with conventional chemotherapy

Advanced Leiomyosarcoma trials by city

Other conditions